Products
EluNIR
- Excellent clinical outcomes
- Redefining deliverability with a new spring tip
- Low footprint cobalt-chromium design
- Optimal conformability and vessel support
- Elastomeric coating and outstanding surface integrity
- Eluting Ridaforolimus, a high therapeutic index limus drug

* Kandzari, David E. et al. Randomized comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stent in Patients with Coronary Artery Disease Circulation (2017) 136: 1304-1314
** Presented at CRT2018
EluNIR - elastomeric Drug Eluting Stent
EluNIR is approved for sale in the US, Japan, CE mark accepting countries, and Israel. For country-specific information please contact Medinol.